Our study showed that in breast cancer cells NGR1 inhibits the RUNX2 AGE signaling pathway, induces Fe2+ accumulation, enhances intracellular oxidative damage, and thus induces ferroptosis slowing down breast cancer cell proliferation. Here, RUNX2 is linked to breast carcinoma.